Incidence of community acquired lower respiratory tract disease in Bristol, UK during the COVID-19 pandemic: A prospective cohort study.

Hyams, Catherine; Challen, Robert; Begier, Elizabeth; Southern, Jo; King, Jade; Morley, Anna; Szasz-Benczur, Zsuzsa; Gonzalez, Maria Garcia; Kinney, Jane; Campling, James; Gray, Sharon; Oliver, Jennifer; Hubler, Robin; Valluri, Srinivas; Vyse, Andrew; McLaughlin, John M; Ellsbury, Gillian; Maskell, Nick A; Gessner, Bradford D; Danon, Leon; Finn, Adam

Hyams, Catherine; Challen, Robert; Begier, Elizabeth; Southern, Jo; King, Jade; Morley, Anna; Szasz-Benczur, Zsuzsa; Gonzalez, Maria Garcia; Kinney, Jane; Campling, James; Gray, Sharon; Oliver, Jennifer; Hubler, Robin; Valluri, Srinivas; Vyse, Andrew; McLaughlin, John M; Ellsbury, Gillian; Maskell, Nick A; Gessner, Bradford D; Danon, Leon; Finn, Adam.

Afiliação

Hyams C; Bristol Vaccine Centre, Population Health Sciences, University of Bristol, UK.
Challen R; Academic Respiratory Unit, University of Bristol, UK.
Begier E; Engineering Mathematics, University of Bristol, UK.
Southern J; Global Medical Development Scientific and Clinical Affairs, Pfizer Vaccines, Ireland.
King J; Vaccines Medical Affairs, Pfizer Ltd, Tadworth KT20 7NS, UK.
Morley A; Clinical Research and Imaging Centre, UHBW NHS Trust, Bristol, UK.
Szasz-Benczur Z; Academic Respiratory Unit, University of Bristol, UK.
Gonzalez MG; Bristol Vaccine Centre, Population Health Sciences, University of Bristol, UK.
Kinney J; Bristol Vaccine Centre, Population Health Sciences, University of Bristol, UK.
Campling J; Bristol Vaccine Centre, Population Health Sciences, University of Bristol, UK.
Gray S; Vaccines Medical Affairs, Pfizer Ltd, Tadworth KT20 7NS, UK.
Oliver J; Vaccines Medical Development, Scientific and Clinical Affairs, Pfizer Inc, Collegeville, PA, USA.
Hubler R; Vaccines Medical Affairs, Pfizer Ltd, Tadworth KT20 7NS, UK.
Valluri S; Vaccines Medical Development, Scientific and Clinical Affairs, Pfizer Inc, Collegeville, PA, USA.
Vyse A; Vaccines Medical Development, Scientific and Clinical Affairs, Pfizer Inc, Collegeville, PA, USA.
McLaughlin JM; Vaccines Medical Affairs, Pfizer Ltd, Tadworth KT20 7NS, UK.
Ellsbury G; Vaccines Medical Development, Scientific and Clinical Affairs, Pfizer Inc, Collegeville, PA, USA.
Maskell NA; Vaccines Medical Affairs, Pfizer Ltd, Tadworth KT20 7NS, UK.
Gessner BD; Academic Respiratory Unit, University of Bristol, UK.
Danon L; Vaccines Medical Development, Scientific and Clinical Affairs, Pfizer Inc, Collegeville, PA, USA.
Finn A; Engineering Mathematics, University of Bristol, UK.

Lancet Reg Health Eur ; 21: 100473, 2022 Oct.

Article em En | MEDLINE | ID: mdl-35965672

Palavras-chave

CAP, community acquired pneumonia; COPD, chronic obstructive pulmonary disease; COVID-19; COVID-19, Coronavirus disease 2019; CRDE, chronic respiratory disease exacerbation; Cardiac failure; HF, heart failure; Lower respiratory tract infection; NP-LRTI, non-pneumonic lower respiratory tract infection; Pneumonia; SARS-CoV-2; aLRTD, acute lower respiratory tract disease

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google